Comments
Loading...
Amylyx Pharma (NASDAQ:AMLX) Stock Quotes, Forecast and News Summary
Amylyx Pharma Stock (NASDAQ: AMLX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Amylyx Pharma (AMLX) stock?
You can purchase shares of Amylyx Pharma (NASDAQ:AMLX) through any online brokerage.
Who are Amylyx Pharma (AMLX) competitors?
Other companies in Amylyx Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and Xeris Biopharma Holdings (NASDAQ:XERS).
What is the forecast, or price target, for Amylyx Pharma (AMLX) stock?
Amylyx Pharma has a consensus price target of $26.89.
What is the current price for Amylyx Pharma (AMLX)?
The stock price for Amylyx Pharma (NASDAQ: AMLX) is $5.2 last updated November 22, 2024 at 10:04 AM EST.
Does Amylyx Pharma (AMLX) pay a dividend?
There are no upcoming dividends for Amylyx Pharma.
When is Amylyx Pharma (NASDAQ:AMLX) reporting earnings?
Amylyx Pharma’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Amylyx Pharma (AMLX) going to split?
There is no upcoming split for Amylyx Pharma.
What sector and industry does Amylyx Pharma (AMLX) operate in?
Amylyx Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.